Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. E. G. Cantafio
Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and in Vivo Evidence
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Low Serum miR-19a Expression as a Novel Poor Prognostic Indicator in Multiple Myeloma
International Journal of Cancer
Cancer Research
Oncology
Curcumin as a Therapeutic Agent: The Evidence From in Vitro, Animal and Human Studies
British Journal of Nutrition
Medicine
Nutrition
Dietetics
A Novel Selective Small-Molecule PI3K Inhibitor Is Effective Against Human Multiple Myeloma in Vitro and in Vivo
Blood Cancer Journal
Oncology
Hematology
STK405759 as a Combination Therapy With Bortezomib or Dexamethasone, in in Vitro and in Vivo Multiple Myeloma Models
Oncotarget
Oncology
Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients
Blood
Biochemistry
Immunology
Cell Biology
Hematology
EZH2 as a Therapeutic Target for Multiple Myeloma and Other Haematological Malignancies
Biomarker Research
Biochemistry
Molecular Medicine
Clinical Biochemistry
MicroRNA-34a (miR-34a)
Science-Business eXchange
A Novel Alkylating Agent Melflufen Induces Irreversible DNA Damage and Cytotoxicity in Multiple Myeloma Cells
British Journal of Haematology
Hematology
The Tumor-Suppressive and Potential Therapeutic Functions of miR-34a in Epithelial Carcinomas
Expert Opinion on Therapeutic Targets
Molecular Medicine
Drug Discovery
Clinical Biochemistry
Pharmacology